home / stock / fbio / fbio articles

FBIO Articles, Fortress Biotech Inc. - From 12/01/23

Stock Information
Company Name: Fortress Biotech Inc.
Stock Symbol: FBIO
Market: NASDAQ
Website: fortressbiotech.com
Menu
FBIO FBIO Quote FBIO Short FBIO News FBIO Articles FBIO Message Board
Get FBIO Alerts

News, Short Squeeze, Breakout and More Instantly...
Avenue Therapeutics to Present at American Epilepsy Society 2023 Annual Meeting | Benzinga

MIAMI, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ:ATXI) ("Avenue" or the "Company"), a specialty pharmaceutical company...
Fortress Biotech Announces Closing of $10.0 Million Public Offering | Benzinga

MIAMI, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ:FBIO) ("Fortress" or "Company"), an innovative biopharmaceutical company...

Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session | Benzinga

Shares of Wynn Resorts, Limited (NASDAQ: WYNN) fell sharply on Friday after the company reported third-quarter financial results. Wynn Resorts repo...

Why Fortress Biotech (FBIO) Shares Are Getting Hammered | Benzinga

Fortress Biotech Inc (NASDAQ: FBIO) shares are trading lower by 38.5% to $1.28 Friday morning after the company announced pricing of a $10 million ...
Dow Gains Over 100 Points; Wynn Resorts Earnings Top Views | Benzinga

U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Friday. Following the market opening Friday, the Dow traded u...

Why Direct Digital Shares Are Trading Higher By Around 33%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of Direct Digital Holdings, Inc. (NASDAQ: DRCT) rose sharply in pre-market trading after the company reported better-than-expected third-qu...

Fortress Biotech Announces Launch of Proposed Public Offering | Benzinga

MIAMI, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ:FBIO) ("Fortress" or "Company"), an innovative biopharmaceutical company...
Avenue Therapeutics Announces Closing of $5.0 Million Public Offering | Benzinga

MIAMI, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ:ATXI) ("Avenue" or the "Company"), a specialty pharmaceutical company...

Mustang Bio Announces MB-106 CD20-Targeted CAR-T Data Selected for Presentation at 65th American Society of Hematology (ASH) Annual Meeting | Benzinga

WORCESTER, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. ("Mustang") (NASDAQ:MBIO), a clinical-stage biopharmaceutical company focu...

Mustang Bio Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules | Benzinga

WORCESTER, Mass., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. ("Mustang" or the "Company") (NASDAQ:MBIO), a clinical-stage biopharmaceut...
Previous 10 Next 10